JAGSNPHARM
JAGSONPAL PHARMACEUTICALS

221.53 +4.35 (+1.97%)

JAGSNPHARM shows sign of weakness as investors do cost averaging

21 Oct, 20255 min read

JAGSNPHARM ranked better than it's peers today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.1% per day. Tuesday's performance of +1.97% was a outperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}